EcoDrugPlus

Aurora Kinase B-Like

Ensembl ID : ENSSLDG00000024189
Gene Symbol: LOC111648179
3 Cross references
205 Possible Orthologues:

Beta-4c Adrenergic Receptor-Like

Ensembl ID : ENSSLDG00000008951
Gene Symbol: LOC111644883
3 Cross references
196 Possible Orthologues:

Beta-Secretase 1

Ensembl ID : ENSSLDG00000008354
Gene Symbol: BACE1
3 Cross references
218 Possible Orthologues:

Bradykinin Receptor B1

Ensembl ID : ENSSLDG00000007482
Gene Symbol: BDKRB1
1 Cross references
147 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSSLDG00000007448
Gene Symbol: BDKRB2
4 Cross references
167 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSSLDG00000007528
Gene Symbol: BDKRB2
3 Cross references
248 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSSLDG00000021904
Gene Symbol: BDKRB2
3 Cross references
155 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSSLDG00000015163
Gene Symbol: BDKRB2
1 Cross references
248 Possible Orthologues:

Breakpoint Cluster Region Protein-Like

Ensembl ID : ENSSLDG00000002959
Gene Symbol: LOC111663954
2 Cross references
70 Possible Orthologues:

Camp-Specific 3',5'-Cyclic Phosphodiesterase 4b-Like

Ensembl ID : ENSSLDG00000022383
Gene Symbol: LOC111670548
2 Cross references
224 Possible Orthologues:

Camp-Specific 3',5'-Cyclic Phosphodiesterase 4c-Like

Ensembl ID : ENSSLDG00000007985
Gene Symbol: LOC111651283
3 Cross references
189 Possible Orthologues:

Calcium Channel, Voltage-Dependent, Beta 3a

Ensembl ID : ENSSLDG00000010401
Gene Symbol: CACNB3A
1 Cross references
196 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).